PDCD1 and neoplasm: We hypothesized that high-dose AA and anti-PD1 cotreatment increased CD8+ T cells and changed the tumor microenvironment; to test this hypothesis, we used immunofluorescence to investigate markers of immune cell infiltration and function in a syngeneic lung tumor.